Bioline Launches Latest ISOLATE II miRNA and RNA Purification Kits

March 17, 2015 Leave a comment 3,217 Views

CINCINNATI – Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc. (NASDAQ:VIVO), is proud to announce the worldwide release of the latest five kits in the high performance ISOLATE II nucleic acid purification range – ISOLATE II miRNA, ...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: ISOLATE II

Bioline Launches Latest ISOLATE II miRNA and RNA Purification Kits

RPKM, FPKM and TPM, clearly explained

How to Analyze RNA-Seq Data?

Visualization of nucleotide substitutions in the (micro)transcriptome

Comparison of TMM (edgeR), RLE (DESeq2), and MRN Normalization Methods

Life Technologies Releases New Research Tool: Oncomine NGS RNA-Seq Gene Expression Browser

Researchers develop online portal to show how biases in RNA sequences affect gene expression

Transcriptional recording enables noninvasive measurement of the intestinal tract with potential for biomedical research and future biomedical diagnostic applications

ActiveSVM – single-cell mRNA-seq data analysis with a minimal number of genes

scRNA-Seq draws a a roadmap to future personalized medicine for heart defects that develop before birth

DestVI – identification of continuums of cell types in spatial transcriptomics data

Researchers develop online portal to show how biases in RNA sequences affect gene expression

Transcriptional recording enables noninvasive measurement of the intestinal tract with potential for biomedical research and future biomedical diagnostic applications

ActiveSVM – single-cell mRNA-seq data analysis with a minimal number of genes

scRNA-Seq draws a a roadmap to future personalized medicine for heart defects that develop before birth

DestVI – identification of continuums of cell types in spatial transcriptomics data

TAS-Seq – terminator-assisted solid-phase cDNA amplification and sequencing for scRNA-seq

Post-doc position available – single-cell multi-omics analyses in a first-in-human gene therapy trial